Latest Insider Transactions at Vanda Pharmaceuticals Inc. (VNDA)
This section provides a real-time view of insider transactions for Vanda Pharmaceuticals Inc. (VNDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vanda Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vanda Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
Thomas Watkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.4%
|
-
|
|
Mar 15
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
18,000
-16.08%
|
$306,000
$17.72 P/Share
|
|
Mar 15
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.82%
|
$165,000
$11.32 P/Share
|
|
Mar 08
2021
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
175,000
-12.54%
|
$3,150,000
$18.0 P/Share
|
|
Mar 05
2021
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
5,600
-3.03%
|
$95,200
$17.87 P/Share
|
|
Mar 02
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
3,865
-3.83%
|
$69,570
$18.04 P/Share
|
|
Mar 02
2021
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,888
-4.74%
|
$69,984
$18.45 P/Share
|
|
Mar 02
2021
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
16,620
-8.83%
|
$299,160
$18.19 P/Share
|
|
Mar 02
2021
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
6,044
-5.62%
|
$108,792
$18.23 P/Share
|
|
Mar 02
2021
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
15,206
-1.08%
|
$273,708
$18.34 P/Share
|
|
Mar 02
2021
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
7,674
-7.66%
|
$138,132
$18.54 P/Share
|
|
Mar 01
2021
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
3,845
-2.0%
|
$69,210
$18.66 P/Share
|
|
Mar 01
2021
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
3,327
-3.0%
|
$59,886
$18.57 P/Share
|
|
Mar 01
2021
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
7,479
-0.53%
|
$134,622
$18.45 P/Share
|
|
Mar 01
2021
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
11,856
-10.58%
|
$213,408
$18.6 P/Share
|
|
Feb 24
2021
|
Gunther Birznieks SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+14.54%
|
-
|
|
Feb 24
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
22,986
-18.57%
|
$459,720
$20.01 P/Share
|
|
Feb 24
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,499
+15.38%
|
$269,988
$12.27 P/Share
|
|
Feb 24
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,800
+20.3%
|
-
|
|
Feb 24
2021
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+22.79%
|
-
|
|
Feb 24
2021
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,000
+7.5%
|
-
|
|
Feb 24
2021
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,800
+23.91%
|
-
|
|
Feb 24
2021
|
Timothy Williams SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+22.59%
|
-
|
|
Feb 16
2021
|
Richard W Dugan |
SELL
Open market or private sale
|
Direct |
5,754
-9.49%
|
$103,572
$18.54 P/Share
|
|
Feb 16
2021
|
Richard W Dugan |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.83%
|
$105,000
$7.11 P/Share
|
|
Feb 16
2021
|
Thomas Watkins Director |
SELL
Open market or private sale
|
Direct |
5,818
-10.52%
|
$104,724
$18.54 P/Share
|
|
Feb 16
2021
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.33%
|
$105,000
$7.11 P/Share
|
|
Dec 15
2020
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
39,150
-2.92%
|
$508,950
$13.0 P/Share
|
|
Dec 15
2020
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,663
+3.36%
|
$373,304
$8.75 P/Share
|
|
Dec 14
2020
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
51,049
-3.79%
|
$663,637
$13.19 P/Share
|
|
Dec 14
2020
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
61,520
+4.37%
|
$492,160
$8.75 P/Share
|
|
Dec 11
2020
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
35,053
-2.65%
|
$420,636
$12.88 P/Share
|
|
Dec 11
2020
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,817
+3.07%
|
$334,536
$8.75 P/Share
|